{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:31:25Z","timestamp":1773293485884,"version":"3.50.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1038\/sj.bmt.1703813","type":"journal-article","created":{"date-parts":[[2003,3,5]],"date-time":"2003-03-05T17:20:10Z","timestamp":1046884810000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Clinical application of hematopoietic progenitor cell expansion: current status and future prospects"],"prefix":"10.1038","volume":"31","author":[{"given":"S M","family":"Devine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S G","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,2,14]]},"reference":[{"key":"BF1703813_CR1","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1126\/science.287.5457.1442","volume":"287","author":"IL Weissman","year":"2000","unstructured":"Weissman IL . Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000; 287: 1442\u20131446.","journal-title":"Science"},{"key":"BF1703813_CR2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni0402-314","volume":"3","author":"CM Verfaillie","year":"2002","unstructured":"Verfaillie CM . Hematopoietic stem cells for transplantation. Nat Immunol 2002; 3: 314\u2013317.","journal-title":"Nat Immunol"},{"issue":"1","key":"BF1703813_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/asheducation-2001.1.375","volume":"2001","author":"R. F. Storb","year":"2001","unstructured":"Storb RF, Champlin R, Riddell SR et al. Non-myeloablative transplants for malignant disease. Hematology. Am Soc Hematol Educ Program 2001; 375\u2013391.","journal-title":"Hematology"},{"key":"BF1703813_CR4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","volume":"339","author":"F Aversa","year":"1998","unstructured":"Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186\u20131193.","journal-title":"N Engl J Med"},{"key":"BF1703813_CR5","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood.V97.10.2957","volume":"97","author":"JN Barker","year":"2001","unstructured":"Barker JN, Davies SM, DeFor T et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957\u20132961.","journal-title":"Blood"},{"key":"BF1703813_CR6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood.V99.6.1943","volume":"99","author":"H Castro-Malaspina","year":"2002","unstructured":"Castro-Malaspina H, Harris RE, Gajewski J et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood 2002; 99: 1943\u20131951.","journal-title":"Blood"},{"key":"BF1703813_CR7","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","volume":"98","author":"C Kollman","year":"2001","unstructured":"Kollman C, Howe CW, Anasetti C et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043\u20132051.","journal-title":"Blood"},{"key":"BF1703813_CR8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V99.3.806","volume":"99","author":"WR Drobyski","year":"2002","unstructured":"Drobyski WR, Klein J, Flomenberg N et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002; 99: 806\u2013814.","journal-title":"Blood"},{"key":"BF1703813_CR9","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0301-472X(00)00540-3","volume":"28","author":"E Gluckman","year":"2000","unstructured":"Gluckman E . Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000; 28: 1197\u20131205.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","volume":"344","author":"MJ Laughlin","year":"2001","unstructured":"Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815\u20131822.","journal-title":"N Engl J Med"},{"key":"BF1703813_CR11","first-page":"3323","volume":"95","author":"AJ Barrett","year":"2000","unstructured":"Barrett AJ, Ringden O, Zhang MJ et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000; 95: 3323\u20133327.","journal-title":"Blood"},{"key":"BF1703813_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1246-7820(01)00132-X","volume":"8","author":"E Gluckman","year":"2001","unstructured":"Gluckman E, Rocha V, Chevret S . Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfusion Clin Biol 2001; 8: 146\u2013154.","journal-title":"Transfusion Clin Biol"},{"key":"BF1703813_CR13","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","volume":"88","author":"D Mavroudis","year":"1996","unstructured":"Mavroudis D, Read E, Cottler-Fox M et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996; 88: 3223\u20133229.","journal-title":"Blood"},{"key":"BF1703813_CR14","first-page":"319","volume":"18","author":"J Mehta","year":"1996","unstructured":"Mehta J, Powles R, Horton C et al. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Bone Marrow Transplant 1996; 18: 319\u2013324.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR15","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1182\/blood.V90.9.3808","volume":"90","author":"J Mehta","year":"1997","unstructured":"Mehta J, Powles R, Treleaven J et al. Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome. Blood 1997; 90: 3808\u20133810.","journal-title":"Blood"},{"key":"BF1703813_CR16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1399-0012.1992.tb00589.x","volume":"6","author":"T Paulin","year":"1992","unstructured":"Paulin T . Importance of bone marrow cell dose in bone marrow transplantation. Clin Transplant 1992; 6: 48\u201354.","journal-title":"Clin Transplant"},{"key":"BF1703813_CR17","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199811263392201","volume":"339","author":"P Rubinstein","year":"1998","unstructured":"Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565\u20131577.","journal-title":"N Engl J Med"},{"key":"BF1703813_CR18","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V99.8.2726","volume":"99","author":"H Bittencourt","year":"2002","unstructured":"Bittencourt H, Rocha V, Chevret S et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 99: 2726\u20132733.","journal-title":"Blood"},{"key":"BF1703813_CR19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1182\/blood.V99.6.2002","volume":"99","author":"AE Woolfrey","year":"2002","unstructured":"Woolfrey AE, Anasetti C, Storer B et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002; 99: 2002\u20132008.","journal-title":"Blood"},{"key":"BF1703813_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1989.tb22415.x","volume":"554","author":"BA Naughton","year":"1989","unstructured":"Naughton BA, Naughton GK . Hematopoiesis on nylon mesh templates. Comparative long-term bone marrow culture and the influence of stromal support cells. Ann NY Acad Sci 1989; 554: 125\u2013140.","journal-title":"Ann NY Acad Sci"},{"key":"BF1703813_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jcp.1041470221","volume":"147","author":"J Caldwell","year":"1991","unstructured":"Caldwell J, Palsson BO, Locey B et al. Culture perfusion schedules influence the metabolic activity and granulocyte\u2013macrophage colony-stimulating factor production rates of human bone marrow stromal cells. J Cell Physiol 1991; 147: 344\u2013353.","journal-title":"J Cell Physiol"},{"key":"BF1703813_CR22","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood.V78.12.3155.bloodjournal78123155","volume":"78","author":"RM Schwartz","year":"1991","unstructured":"Schwartz RM, Emerson SG, Clarke MF et al. In vitro myelopoiesis stimulated by rapid medium exchange and supplementation with hematopoietic growth factors. Blood 1991; 78: 3155\u20133161.","journal-title":"Blood"},{"key":"BF1703813_CR23","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.88.15.6760","volume":"88","author":"RM Schwartz","year":"1991","unstructured":"Schwartz RM, Palsson BO, Emerson SG . Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures. Proc Natl Acad Sci USA 1991; 88: 6760\u20136764.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V80.6.1405.bloodjournal8061405","volume":"80","author":"DN Haylock","year":"1992","unstructured":"Haylock DN, To LB, Dowse TL et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405\u20131412.","journal-title":"Blood"},{"key":"BF1703813_CR25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1749-6632.1999.tb08475.x","volume":"872","author":"K Kaushansky","year":"1999","unstructured":"Kaushansky K . Thrombopoietin and hematopoietic stem cell development. Ann NY Acad Sci 1999; 872: 314\u2013319.","journal-title":"Ann NY Acad Sci"},{"key":"BF1703813_CR26","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.94.10.5320","volume":"94","author":"M Bhatia","year":"1997","unstructured":"Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5320\u20135325.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR27","first-page":"980","volume":"25","author":"R Bhatia","year":"1997","unstructured":"Bhatia R, McGlave PB, Miller JS et al. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium. Exp Hematol 1997; 25: 980\u2013991.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1182\/blood.V91.4.1206","volume":"91","author":"KM Luens","year":"1998","unstructured":"Luens KM, Travis MA, Chen BP et al. Thrombopoietin, kit ligand, and flk2\/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 1998; 91: 1206\u20131215.","journal-title":"Blood"},{"key":"BF1703813_CR29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1073\/pnas.93.4.1470","volume":"93","author":"AL Petzer","year":"1996","unstructured":"Petzer AL, Hogge DE, Landsdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93: 1470\u20131474.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR30","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1182\/blood.V93.11.3736","volume":"93","author":"W Piacibello","year":"1999","unstructured":"Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736\u20133749.","journal-title":"Blood"},{"key":"BF1703813_CR31","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.94.18.9836","volume":"94","author":"E Conneally","year":"1997","unstructured":"Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid\/scid mice. Proc Natl Acad Sci USA 1997; 94: 9836\u20139841.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR32","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1182\/blood.V92.12.4612.424k04_4612_4621","volume":"92","author":"MA Dao","year":"1998","unstructured":"Dao MA, Hashino K, Kato I et al. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 1998; 92: 4612\u20134621.","journal-title":"Blood"},{"key":"BF1703813_CR33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00062752-199905000-00010","volume":"6","author":"R Hoffman","year":"1999","unstructured":"Hoffman R . Progress in the development of systems for in vitro expansion of human hematopoietic stem cells. Curr Opin Hematol 1999; 6: 184\u2013191.","journal-title":"Curr Opin Hematol"},{"key":"BF1703813_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0301-472X(00)00610-X","volume":"29","author":"I McNiece","year":"2001","unstructured":"McNiece I, Briddell R . Ex vivo expansion of hematopoietic progenitor cells and mature cells. Exp Hematol 2001; 29: 3\u201311.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V80.7.1673.1673","volume":"80","author":"E Naparstek","year":"1992","unstructured":"Naparstek E, Hardan Y, Ben-Shahar M et al. Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte\u2013macrophage colony-stimulating factor. Blood 1992; 80: 1673\u20131678.","journal-title":"Blood"},{"key":"BF1703813_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM199508033330503","volume":"333","author":"W Brugger","year":"1995","unstructured":"Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995; 333: 283\u2013287.","journal-title":"N Engl J Med"},{"key":"BF1703813_CR37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJM200107053450112","volume":"345","author":"L Kanz","year":"2001","unstructured":"Kanz L, Brugger W . Retraction: reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 2001; 345: 64.","journal-title":"N Engl J Med"},{"key":"BF1703813_CR38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V87.5.1687.1687","volume":"87","author":"SF Williams","year":"1996","unstructured":"Williams SF, Lee WJ, Bender JG et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 1687\u20131691.","journal-title":"Blood"},{"key":"BF1703813_CR39","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1200\/JCO.1996.14.6.1839","volume":"14","author":"MJ Alcorn","year":"1996","unstructured":"Alcorn MJ, Holyoake TL, Richmond L et al. CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996; 14: 1839\u20131847.","journal-title":"J Clin Oncol"},{"key":"BF1703813_CR40","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.bmt.1700799","volume":"19","author":"TL Holyoake","year":"1997","unstructured":"Holyoake TL, Alcorn MJ, Richmond L et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens. Bone Marrow Transplant 1997; 19: 1095\u20131101.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR41","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V96.7.2385","volume":"96","author":"RL Paquette","year":"2000","unstructured":"Paquette RL, Dergham ST, Karpf E et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000; 96: 2385\u20132390.","journal-title":"Blood"},{"key":"BF1703813_CR42","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(99)03113-X","volume":"354","author":"J Reiffers","year":"1999","unstructured":"Reiffers J, Cailliot C, Dazey B et al. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092\u20131093.","journal-title":"Lancet"},{"key":"BF1703813_CR43","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V96.9.3001","volume":"96","author":"I McNiece","year":"2000","unstructured":"McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001\u20133007.","journal-title":"Blood"},{"key":"BF1703813_CR44","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V95.6.2169","volume":"95","author":"P Stiff","year":"2000","unstructured":"Stiff P, Chen B, Franklin W et al. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 2000; 95: 2169\u20132174.","journal-title":"Blood"},{"key":"BF1703813_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1432-0436.1986.tb00391.x","volume":"31","author":"E Spooncer","year":"1986","unstructured":"Spooncer E, Heyworth CM, Dunn A et al. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 1986; 31: 111\u2013118.","journal-title":"Differentiation"},{"key":"BF1703813_CR46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bmt.1702788","volume":"27","author":"M Engelhardt","year":"2001","unstructured":"Engelhardt M, Douville J, Behringer D et al. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy. Bone Marrow Transplant 2001; 27: 249\u2013259.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701314","volume":"22","author":"BI Lundell","year":"1998","unstructured":"Lundell BI, Vredenburgh JJ, Tyer C et al. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging. Bone Marrow Transplant 1998; 22: 153\u2013159.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR48","doi-asserted-by":"crossref","first-page":"15346","DOI":"10.1073\/pnas.93.26.15346","volume":"93","author":"EG Hanania","year":"1996","unstructured":"Hanania EG, Giles RE, Kavanagh J et al. Results of MDR-1 vector modification trial indicate that granulocyte\/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 1996; 93: 15346\u201315351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1998.16.1.165","volume":"16","author":"C Hesdorffer","year":"1998","unstructured":"Hesdorffer C, Ayello J, Ward M et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998; 16: 165\u2013172.","journal-title":"J Clin Oncol"},{"key":"BF1703813_CR50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/blood.V94.1.106.413k01_106_113","volume":"94","author":"JE Brandt","year":"1999","unstructured":"Brandt JE, Bartholomew AM, Fortman JD et al. Ex vivo expansion of autologous bone marrow CD34(+) cells with porcine microvascular endothelial cells results in a graft capable of rescuing lethally irradiated baboons. Blood 1999; 94: 106\u2013113.","journal-title":"Blood"},{"key":"BF1703813_CR51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V93.3.1097","volume":"93","author":"G Guenechea","year":"1999","unstructured":"Guenechea G, Segovia JC, Albella B et al. Delayed engraftment of nonobese diabetic\/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999; 93: 1097\u20131105.","journal-title":"Blood"},{"key":"BF1703813_CR52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V87.1.30.30","volume":"87","author":"SO Peters","year":"1996","unstructured":"Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30\u201337.","journal-title":"Blood"},{"key":"BF1703813_CR53","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1084\/jem.156.6.1767","volume":"156","author":"DE Harrison","year":"1982","unstructured":"Harrison DE, Astle CM . Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J Exp Med 1982; 156: 1767\u20131779.","journal-title":"J Exp Med"},{"key":"BF1703813_CR54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V92.4.1131","volume":"92","author":"JF Tisdale","year":"1998","unstructured":"Tisdale JF, Hanazono Y, Sellers SE et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 1998; 92: 1131\u20131141.","journal-title":"Blood"},{"key":"BF1703813_CR55","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0301-472X(01)00751-2","volume":"29","author":"SJ Szilvassy","year":"2001","unstructured":"Szilvassy SJ, Meyerrose TE, Ragland PL et al. Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of beta1 integrin. Exp Hematol 2001; 29: 1494\u20131502.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/sj.bmt.1701157","volume":"21","author":"MR Koller","year":"1998","unstructured":"Koller MR, Manchel I, Maher RJ et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998; 21: 653\u2013663.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR57","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1537-2995.1997.37797369451.x","volume":"37","author":"D Adkins","year":"1997","unstructured":"Adkins D, Spitzer G, Johnston M et al. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 1997; 37: 737\u2013748.","journal-title":"Transfusion"},{"key":"BF1703813_CR58","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1182\/blood.V95.11.3605","volume":"95","author":"DR Adkins","year":"2000","unstructured":"Adkins DR, Goodnough LT, Shenoy S et al. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation. Blood 2000; 95: 3605\u20133612.","journal-title":"Blood"},{"key":"BF1703813_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/shem.2002.30913","volume":"39","author":"J Barrett","year":"2002","unstructured":"Barrett J, Childs R . New directions in allogeneic stem cell transplantation. Semin Hematol 2002; 39: 1\u20132.","journal-title":"Semin Hematol"},{"key":"BF1703813_CR60","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BF1703813_CR61","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","volume":"97","author":"V Rocha","year":"2001","unstructured":"Rocha V, Cornish J, Sievers EL et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962\u20132971.","journal-title":"Blood"},{"key":"BF1703813_CR62","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood.V90.12.4665","volume":"90","author":"MS Cairo","year":"1997","unstructured":"Cairo MS, Wagner JE . Placental and\/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997; 90: 4665\u20134678.","journal-title":"Blood"},{"key":"BF1703813_CR63","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V98.9.2791","volume":"98","author":"JN Barker","year":"2001","unstructured":"Barker JN, Weisdorf DJ, DeFor TE et al. Impact of multiple unit unrelated donor umbilical cord blood transplantation in adults: preliminary analysis of safety and efficacy. Blood 2001; 98: 2791.","journal-title":"Blood"},{"key":"BF1703813_CR64","first-page":"646a","volume":"92","author":"P Stiff","year":"1998","unstructured":"Stiff P, Pecora A, Parthasarathy M et al. Umbilical cord blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: preliminary clinical observations. Blood 1998; 92: 646a.","journal-title":"Blood"},{"key":"BF1703813_CR65","first-page":"646a","volume":"92","author":"EJ Shpall","year":"1998","unstructured":"Shpall EJ, Quinones R, Hami L et al. Transplantation of cancer patients receiving high dose chemotherapy with ex vivo expanded cord blood cells. Blood 1998; 92: 646a.","journal-title":"Blood"},{"key":"BF1703813_CR66","first-page":"646a","volume":"92","author":"J Jaroscak","year":"1998","unstructured":"Jaroscak J, Martin PL, Waters-Pick B et al. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells. Blood 1998; 92: 646a.","journal-title":"Blood"},{"key":"BF1703813_CR67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/sj.bmt.1702222","volume":"25","author":"AL Pecora","year":"2000","unstructured":"Pecora AL, Stiff P, Jennis A et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000; 25: 797\u2013799.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl. 1","key":"BF1703813_CR68","first-page":"177","volume":"16","author":"C Eaves","year":"1998","unstructured":"Eaves C, Zandstra P, Conneally E et al. Changes in the cytokine regulation of stem cell self-renewal during ontogeny. Stem Cells 1998; 16 (Suppl. 1): 177\u2013184.","journal-title":"Stem Cells"},{"key":"BF1703813_CR69","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0301-472X(99)00078-8","volume":"27","author":"TL Holyoake","year":"1999","unstructured":"Holyoake TL, Nicolini FE, Eaves CJ . Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999; 27: 1418\u20131427.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR70","first-page":"187","volume":"23","author":"PM Lansdorp","year":"1995","unstructured":"Lansdorp PM . Developmental changes in the function of hematopoietic stem cells. Exp Hematol 1995; 23: 187\u2013191.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR71","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood.V94.8.2686.420k15_2686_2695","volume":"94","author":"FE Nicolini","year":"1999","unstructured":"Nicolini FE, Holyoake TL, Cashman JD et al. Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD\/SCID mice. Blood 1999; 94: 2686\u20132695.","journal-title":"Blood"},{"key":"BF1703813_CR72","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood.V96.13.4160","volume":"96","author":"IH Oh","year":"2000","unstructured":"Oh IH, Lau A, Eaves CJ . During ontogeny primitive (CD34(+)CD38(\u2212)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts. Blood 2000; 96: 4160\u20134168.","journal-title":"Blood"},{"key":"BF1703813_CR73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1365-2141.1998.00777.x","volume":"101","author":"PW Zandstra","year":"1998","unstructured":"Zandstra PW, Conneally E, Piret JM et al. Ontogeny-associated changes in the cytokine responses of primitive human haemopoietic cells. Br J Haematol 1998; 101: 770\u2013778.","journal-title":"Br J Haematol"},{"key":"BF1703813_CR74","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1182\/blood.V87.8.3500.bloodjournal8783500","volume":"87","author":"VI Rebel","year":"1996","unstructured":"Rebel VI, Miller CL, Eaves CJ et al. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood 1996; 87: 3500\u20133507.","journal-title":"Blood"},{"key":"BF1703813_CR75","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/stem.160153","volume":"16","author":"H Mayani","year":"1998","unstructured":"Mayani H, Lansdorp PM . Biology of human umbilical cord blood-derived hematopoietic stem\/progenitor cells. Stem Cells 1998; 16: 153\u2013165.","journal-title":"Stem Cells"},{"key":"BF1703813_CR76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1537-2995.2001.41020213.x","volume":"41","author":"R Xu","year":"2001","unstructured":"Xu R, Reems JA . Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion 2001; 41: 213\u2013218.","journal-title":"Transfusion"},{"key":"BF1703813_CR77","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V95.10.3102","volume":"95","author":"O Kollet","year":"2000","unstructured":"Kollet O, Peled A, Byk T et al. beta2 microglobulin-deficient (B2m(null)) NOD\/SCID mice are excellent recipients for studying human stem cell function. Blood 2000; 95: 3102\u20133105.","journal-title":"Blood"},{"key":"BF1703813_CR78","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood.V96.10.3414","volume":"96","author":"ES Rosler","year":"2000","unstructured":"Rosler ES, Brandt JE, Chute J et al. An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells. Blood 2000; 96: 3414\u20133421.","journal-title":"Blood"},{"key":"BF1703813_CR79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood.V95.1.102","volume":"95","author":"C Dorrell","year":"2000","unstructured":"Dorrell C, Gan OI, Pereira DS et al. Expansion of human cord blood CD34(+)CD38(\u2212) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 2000; 95: 102\u2013110.","journal-title":"Blood"},{"key":"BF1703813_CR80","first-page":"1162","volume":"26","author":"S Huang","year":"1998","unstructured":"Huang S, Law P, Young D et al. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp Hematol 1998; 26: 1162\u20131171.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR81","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.186.4.619","volume":"186","author":"M Bhatia","year":"1997","unstructured":"Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997; 186: 619\u2013624.","journal-title":"J Exp Med"},{"key":"BF1703813_CR82","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI8583","volume":"105","author":"T Ueda","year":"2000","unstructured":"Ueda T, Tsuji K, Yoshino H et al. Expansion of human NOD\/SCID-repopulating cells by stem cell factor, Flk2\/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest 2000; 105: 1013\u20131021.","journal-title":"J Clin Invest"},{"key":"BF1703813_CR83","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0301-472X(01)00750-0","volume":"29","author":"GH Danet","year":"2001","unstructured":"Danet GH, Lee HW, Luongo JL et al. Dissociation between stem cell phenotype and NOD\/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol 2001; 29: 1465\u20131473.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR84","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bmt.1702810","volume":"27","author":"C Donaldson","year":"2001","unstructured":"Donaldson C, Denning-Kendall P, Bradley B et al. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function. Bone Marrow Transplant 2001; 27: 365\u2013371.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR85","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1296-1329","volume":"2","author":"A Larochelle","year":"1996","unstructured":"Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD\/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996; 2: 1329\u20131337.","journal-title":"Nat Med"},{"key":"BF1703813_CR86","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood.V90.1.464","volume":"90","author":"B Albella","year":"1997","unstructured":"Albella B, Segovia JC, Bueren JA . Does the granulocyte\u2013macrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes? Blood 1997; 90: 464\u2013470.","journal-title":"Blood"},{"key":"BF1703813_CR87","doi-asserted-by":"crossref","first-page":"11871","DOI":"10.1073\/pnas.93.21.11871","volume":"93","author":"CE Dunbar","year":"1996","unstructured":"Dunbar CE, Seidel NE, Doren S et al. Improved retroviral gene transfer into murine and Rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1996; 93: 11871\u201311876.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR88","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood.V98.7.2108","volume":"98","author":"SJ Szilvassy","year":"2001","unstructured":"Szilvassy SJ, Meyerrose TE, Ragland PL et al. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 2001; 98: 2108\u20132115.","journal-title":"Blood"},{"key":"BF1703813_CR89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2141.2001.03084.x","volume":"115","author":"M Ramirez","year":"2001","unstructured":"Ramirez M, Segovia JC, Benet I et al. Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins. Br J Haematol 2001; 115: 213\u2013221.","journal-title":"Br J Haematol"},{"key":"BF1703813_CR90","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1084\/jem.181.5.1805","volume":"181","author":"JP Levesque","year":"1995","unstructured":"Levesque JP, Leavesley DI, Niutta S et al. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 1995; 181: 1805\u20131815.","journal-title":"J Exp Med"},{"key":"BF1703813_CR91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI118063","volume":"96","author":"RW Hurley","year":"1995","unstructured":"Hurley RW, McCarthy JB, Verfaillie CM . Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 1995; 96: 511\u2013519.","journal-title":"J Clin Invest"},{"key":"BF1703813_CR92","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0301-472X(00)00682-2","volume":"29","author":"O Giet","year":"2001","unstructured":"Giet O, Huygen S, Beguin Y et al. Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Exp Hematol 2001; 29: 515\u2013524.","journal-title":"Exp Hematol"},{"key":"BF1703813_CR93","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/blood.V96.13.4185","volume":"96","author":"H Glimm","year":"2000","unstructured":"Glimm H, Oh IH, Eaves CJ . Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S\/G(2)\/M transit and do not reenter G(0). Blood 2000; 96: 4185\u20134193.","journal-title":"Blood"},{"key":"BF1703813_CR94","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/stem.170210","volume":"17","author":"RG Andrews","year":"1999","unstructured":"Andrews RG, Briddell RA, Hill R et al. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia. Stem Cells 1999; 17: 210\u2013218.","journal-title":"Stem Cells"},{"key":"BF1703813_CR95","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI11519","volume":"107","author":"H Glimm","year":"2001","unstructured":"Glimm H, Eisterer W, Lee K et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD\/SCID-beta2 microglobulin-null mice. J Clin Invest 2001; 107: 199\u2013206.","journal-title":"J Clin Invest"},{"key":"BF1703813_CR96","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V95.3.855.003k41_855_862","volume":"95","author":"RA Oostendorp","year":"2000","unstructured":"Oostendorp RA, Audet J, Eaves CJ . High-resolution tracking of cell division suggests similar cell cycle kinetics of hematopoietic stem cells stimulated in vitro and in vivo. Blood 2000; 95: 855\u2013862.","journal-title":"Blood"},{"key":"BF1703813_CR97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.leu.2401373","volume":"13","author":"RA Oostendorp","year":"1999","unstructured":"Oostendorp RA, Audet J, Miller C et al. Cell division tracking and expansion of hematopoietic long-term repopulating cells. Leukemia 1999; 13: 499\u2013501.","journal-title":"Leukemia"},{"key":"BF1703813_CR98","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood.V90.11.4384","volume":"90","author":"A Gothot","year":"1997","unstructured":"Gothot A, Pyatt R, McMahel J et al. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 \/G1 phase of the cell cycle. Blood 1997; 90: 4384\u20134393.","journal-title":"Blood"},{"key":"BF1703813_CR99","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V92.8.2641","volume":"92","author":"A Gothot","year":"1998","unstructured":"Gothot A, van der Loo JC, Clapp DW et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic\/severe combined immune-deficient mice. Blood 1998; 92: 2641\u20132649.","journal-title":"Blood"},{"key":"BF1703813_CR100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.188.2.393","volume":"188","author":"HK Habibian","year":"1998","unstructured":"Habibian HK, Peters SO, Hsieh CC et al. The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J Exp Med 1998; 188: 393\u2013398.","journal-title":"J Exp Med"},{"key":"BF1703813_CR101","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1634\/stemcells.19-6-505","volume":"19","author":"YJ Summers","year":"2001","unstructured":"Summers YJ, Heyworth CM, de Wynter EA et al. Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cells. Stem Cells 2001; 19: 505\u2013513.","journal-title":"Stem Cells"},{"key":"BF1703813_CR102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1701097","volume":"21","author":"WE Nibley","year":"1998","unstructured":"Nibley WE, Spangrude GJ . Primitive stem cells alone mediate rapid marrow recovery and multilineage engraftment after transplantation. Bone Marrow Transplant 1998; 21: 345\u2013354.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703813_CR103","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1073\/pnas.95.2.725","volume":"95","author":"JM Zijlmans","year":"1998","unstructured":"Zijlmans JM, Visser JW, Laterveer L et al. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc Natl Acad Sci USA 1998; 95: 725\u2013729.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR104","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI1681","volume":"101","author":"N Uchida","year":"1998","unstructured":"Uchida N, Tsukamoto A, He D et al. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest 1998; 101: 961\u2013966.","journal-title":"J Clin Invest"},{"key":"BF1703813_CR105","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/bbmt.2001.v7.pm11787531","volume":"7","author":"JM Vose","year":"2001","unstructured":"Vose JM, Bierman PJ, Lynch JC et al. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant 2001; 7: 680\u2013687.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703813_CR106","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1083-8791(00)70008-5","volume":"6","author":"RS Negrin","year":"2000","unstructured":"Negrin RS, Atkinson K, Leemhuis T et al. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 2000; 6: 262\u2013271.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703813_CR107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI9094","volume":"105","author":"MA Moore","year":"2000","unstructured":"Moore MA . Umbilical cord blood: an expandable resource. J Clin Invest 2000; 105: 855\u2013856.","journal-title":"J Clin Invest"},{"key":"BF1703813_CR108","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood.V88.8.2871.bloodjournal8882871","volume":"88","author":"K Takenaka","year":"1996","unstructured":"Takenaka K, Nagafuji K, Harada M et al. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 1996; 88: 2871\u20132877.","journal-title":"Blood"},{"key":"BF1703813_CR109","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.192.9.1365","volume":"192","author":"FN Karanu","year":"2000","unstructured":"Karanu FN, Murdoch B, Gallacher L et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192: 1365\u20131372.","journal-title":"J Exp Med"},{"key":"BF1703813_CR110","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1182\/blood.V91.11.4084","volume":"91","author":"B Varnum-Finney","year":"1998","unstructured":"Varnum-Finney B, Purton LE, Yu M et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998; 91: 4084\u20134091.","journal-title":"Blood"},{"key":"BF1703813_CR111","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.0007-1048.2001.03316.x","volume":"116","author":"T Peled","year":"2002","unstructured":"Peled T, Landau E, Prus E et al. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol 2002; 116: 655\u2013661.","journal-title":"Br J Haematol"},{"key":"BF1703813_CR112","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1126\/science.287.5459.1804","volume":"287","author":"T Cheng","year":"2000","unstructured":"Cheng T, Rodrigues N, Shen H et al. Hematopoietic stem cell quiescence maintained by p21cip1\/waf1. Science 2000; 287: 1804\u20131808.","journal-title":"Science"},{"key":"BF1703813_CR113","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.192.10.1479","volume":"192","author":"DM Giannola","year":"2000","unstructured":"Giannola DM, Shlomchik WD, Jegathesan M et al. Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2. J Exp Med 2000; 192: 1479\u20131490.","journal-title":"J Exp Med"},{"key":"BF1703813_CR114","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood.V92.3.908","volume":"92","author":"O Ohneda","year":"1998","unstructured":"Ohneda O, Fennie C, Zheng Z et al. Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad-mesonephros region-derived endothelium. Blood 1998; 92: 908\u2013919.","journal-title":"Blood"},{"key":"BF1703813_CR115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","volume":"176","author":"MK Majumdar","year":"1998","unstructured":"Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57\u201366.","journal-title":"J Cell Physiol"},{"key":"BF1703813_CR116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143\u2013147.","journal-title":"Science"},{"key":"BF1703813_CR117","first-page":"3537","volume":"98","author":"I McNiece","year":"2001","unstructured":"McNiece I, Harrington JA, James RI et al. Ex vivo expansion of cord blood cells without CD34 selection using co-culture on MSC. Blood 2001; 98: 3537.","journal-title":"Blood"},{"key":"BF1703813_CR118","first-page":"5118","volume":"98","author":"M Kraus","year":"2001","unstructured":"Kraus M, Pang L, Wilder P . Selective expansion of distinct populations in umbilical cord blood using various antibody cocktail selection strategies. Blood 2001; 98: 5118.","journal-title":"Blood"},{"key":"BF1703813_CR119","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145\u20131147.","journal-title":"Science"},{"key":"BF1703813_CR120","doi-asserted-by":"crossref","first-page":"10716","DOI":"10.1073\/pnas.191362598","volume":"98","author":"DS Kaufman","year":"2001","unstructured":"Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2001; 98: 10716\u201310721.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1703813_CR121","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1172\/JCI12593","volume":"108","author":"M Takatoku","year":"2001","unstructured":"Takatoku M, Sellers S, Agricola BA, Metzger ME, Kato I, Donahue RE, and Dunbar CE . Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 2001; 108: 447\u2013455.","journal-title":"J Clin Invest"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703813","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:30:48Z","timestamp":1733956248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,2,1]]}},"alternative-id":["BF1703813"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703813","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]},"assertion":[{"value":"14 February 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}